Predictors of the Effectiveness of Psychological Support in Addition to the Base Treatment in Pulmonary Tuberculosis

Predictors of the Effectiveness of Psychological Support in Addition to the Base Treatment in Pulmonary Tuberculosis

The aim of the study was to investigate the effect on the psycho-emotional state and adherence to treatment in patients with pulmonary tuberculosis of remaxol inclusion in the accompanying therapy regimens.Material and methods. The data from 326 patients (252 men and 74 women) with various forms of...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. M. Kolomiets, A. L. Kovalenko, E. P. Pavlenko, A. Yu. Petrov, E. V. Talikova
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2024-01-01
Series:	Антибиотики и Химиотерапия
Subjects:	tuberculosis remaxol adherence to treatment drug-induced liver damage cytokine profile treatment effectiveness
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/1082
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The eﬀectiveness of psychological support with the use of hepato-immunoprotectors as predictors in drug therapy of tuberculosis
by: V. M. Kolomiets, et al.
Published: (2021-08-01)

Efficiency of Remaxol Use in Supporting Treatment of Advanced Tuberculosis
by: V. M. Kolomiets, et al.
Published: (2020-05-01)

Some Peculiarities of Modern Comorbid Tuberculosis Therapy
by: V. M. Kolomiets, et al.
Published: (2023-02-01)

The Effectiveness of a Succinate-Containing Medication in Accompanying Therapy of Comorbid Tuberculosis in a Penitentiary Institution
by: V. M. Kolomiets, et al.
Published: (2020-12-01)

Comorbid Tuberculosis in the Context of the Formation of a Local Epidemic Situation
by: V. M. Kolomiets, et al.
Published: (2025-02-01)

Accompanying Immunomodulatory Therapy in Treatment of Patients with Neglected Tuberculosis
by: V. M. Kolomiets, et al.
Published: (2020-05-01)

Remaxol Hepatoprotective Therapy of Patients with Tuberculosis and HIV Infection in Day Unit of Tuberculosis Dispensary
by: E. V. Shevyreva, et al.
Published: (2020-05-01)

DRUG-INDUCED LIVER LESIONS AND THEIR MANAGEMENT IN THE MANIFESTATIONS OF TUBERCULOSIS
by: A. V. Mordyk, et al.
Published: (2015-09-01)

Therapy and Rehabilitation of Patients with Pulmonary Tuberculosis and Different Treatment Adherence
by: N. V. Rubleva, et al.
Published: (2020-05-01)

The Problem of Comorbid Socially Significant Infections Under The Conditions of The COVID-19 Pandemic
by: V. M. KOLOMIETS, et al.
Published: (2022-11-01)

Epidemic situation and features of accompanying therapy in the treatment of socially significant infectious diseases in penitentiary populations before, during, and after the COVID-19 pandemic
by: V. M. Kolomiets, et al.
Published: (2024-04-01)

Problem of treatment adherence in tuberculosis patients
by: A. V. Belostotsky, et al.
Published: (2015-04-01)

EFFICACY OF REMAXOL AND ADEMETHIONINE IN EXPERIMENTAL LIVER DAMAGE CAUSED BY A COMBINATION OF RESERVE-SERIES ANTITUBERCULOSIS DRUGS AND ALCOHOL
by: D. S. Sukhanov, et al.
Published: (2014-04-01)

Evaluating Adherence to Medication among Tuberculosis Patients
by: Komal Kapoor, et al.
Published: (2025-03-01)

Investigation of Remaxol Efficacy in Complex Therapy of Experimental Generalized Tuberculosis on Mice
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

Dynamics of cytokine profile indexes in children with first diagnosed pulmonary tuberculosis in the course of antimycobacterial therapy
by: O. M. Raznatovska, et al.
Published: (2018-04-01)

Hepatotropic Therapy in Treatment of Liver Injury
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

Effects of missed anti-tuberculosis therapy doses on treatment outcome: a multi-center cohort studyResearch in context
by: Isabella B.B. Ferreira, et al.
Published: (2025-08-01)

Development and validation of a digital health application to support tuberculosis treatment adherence
by: C. Andrade-Sales, et al.
Published: (2025-07-01)

Endobronchial valve block in the treatment of patients with destructive pulmonary tuberculosis and low adherence to therapy with anti-tuberculosis drugs and refusing to stay in hospital
by: P. A. Fadeev, et al.
Published: (2020-01-01)

A Unique Case of Cure of the Patient with Disseminated Bilateral Fibrous Cavernous Pulmonary Tuberculosis with Extensive Drug Resistance after 18 Years of Treatment Failures
by: O. G. Komissarova, et al.
Published: (2024-12-01)

Sociodemographic factors affecting knowledge levels of tuberculosis patients in New Delhi
by: Ilham Zaidi, et al.
Published: (2024-11-01)

IMPACT OF THE FORM OF MEDICATION ON TREATMENT ADHERENCE IN RESPIRATORY TUBERCULOSIS PATIENTS
by: T. E. Tyulkova, et al.
Published: (2018-01-01)

Psychological support in the formation of adherence to the treatment of patients with tuberculosis
by: P. A. Maier, et al.
Published: (2024-04-01)

Development and description of a theory-driven, evidence-based, complex intervention to improve adherence to treatment for tuberculosis in the UK: the IMPACT study
by: Annie S. K. Jones, et al.
Published: (2024-12-01)

Methodology of the Treatment of Pulmonary Tuberculosis
by: Frayt V., et al.
Published: (2013-03-01)

Clinical course features of newly diagnosed pulmonary tuberculosis treatment failure
by: R. M. Yasinskyi, et al.
Published: (2016-06-01)

Pharmacist-led education intervention to improve pulmonary tuberculosis treatment adherence through the Health Belief Model in Malaysia: a study protocol for a randomized controlled trial
by: Rabbiya Ahmad, et al.
Published: (2025-06-01)

Impact of patient counseling on medication adherence and drug resistance patterns in tuberculosis patients
by: Sanatkumar Bharamu Nyamagoud, et al.
Published: (2025-06-01)

СHEALTH EDUCATION AND ADHERENCE FORMATION IN SOCIALLY VULNERABLE GROUPS OF TUBERCULOSIS PATIENTS
by: K. R. Amlaev, et al.
Published: (2014-10-01)

EFFICIENCY OF COMBINATION TREATMENT IN OUTPATIENTS WITH NEW-ONSET PULMONARY TUBERCULOSIS
by: E. V. Glotova, et al.
Published: (2014-04-01)

Application of Hepatoprotector Remaxol in the Treatment of Patients Co-Infected with Tuberculosis, HIV, and Chronic Hepatitis C
by: YU. G. Pritulina, et al.
Published: (2020-05-01)

TB-Monitor: Advancing Tuberculosis Management Through Innovative Technologies
by: Costin Teodor STREBA, et al.
Published: (2025-05-01)

MORPHOLOGICAL FEATURES OF BRONCHOPULMONARY SYSTEM OF PATIENTS WITH PULMONARY TUBERCULOSIS
by: E. V. Pavlova
Published: (2017-01-01)

Surgical treatment of pulmonary tuberculosis in children
by: M. S. Opanasenko, et al.
Published: (2019-10-01)

Treatment Adherence and Outcomes in Patients with Tuberculosis Treated with Telemedicine: A Scoping Review
by: Kikelomo Sabainah Olowoyo, et al.
Published: (2025-03-01)

Treatment adherence and its association with family support among pulmonary tuberculosis patients in Jinja, Eastern Uganda
by: Businge Alinaitwe, et al.
Published: (2025-04-01)

Treatment of tuberculosis under the view of the user
by: Ana Angélica Lima Dias, et al.
Published: (2013-12-01)

What are the reasons for patients not adhering to their anti-TB treatment in a South African district hospital?
by: Somasundran Govender, et al.
Published: (2009-12-01)

Immunomodulators in Maintenance Therapy of Tuberculosis With Its Patomorphosis Features Taken Into Consideration
by: V. M. Kolomiets, et al.
Published: (2020-05-01)